For Consumers

FDA Office of Women's Health Update Archive

 

 

The words e-update with blue background

The Office of Women's Health e-Update highlights women's health initiatives, meetings, and regulatory safety information from the U.S. Food and Drug Administration (FDA). The e-Update is disseminated via email to the public.

Current Issue: August 2016

Message from the Director

 
As we close out yet another busy summer, OWH is working to advance our many scientific and outreach projects. I encourage you to read this update to learn more about resources for back to school planning, clinical trials outreach and breastfeeding mothers. In addition, you will find opportunities to make your voice heard at FDA and other information on FDA regulated products. Follow us on Twitter disclaimer iconto stay up to date on topics like Zika, clinical trials and other women’s health content that matter to you.
 
Marsha Henderson - Assistant Commissioner for Women’s Health
 
********************************

FDA Women’s Health Highlights

New Blog: Busting 5 Common Myths about FDA and Women’s Health

FDA looks for sex differences when reviewing products and works to address sex differences and women’s health through our research, guidance for industry, scientific meetings, trainings, and other activities. Check out the latest OWH blog that counters common myths about FDA’s women’s health efforts.
 
 
********************************  

Back To School Resources

********************************  

Spread the Word about Women in Clinical Trials

OWH’s Diverse Women in Clinical Trials Awareness Campaign continues to educate women about the importance of participating in clinical trials. Use our new partner toolkit to raise awareness in your community. The toolkit includes sample social media messages and other resources in English and Spanish to help in your outreach.  

Download the Women in Clinical Trials Toolkit

*********************************

Extras 

Public Workshop on Diabetes

On August 29, 2016, FDA’s Center for Drug Evaluation and Research (CDER), is sponsoring a public workshop entitled “Diabetes Outcome Measures Beyond Hemoglobin A1c (HbA1c).”
 
The purpose of this public workshop is to have a forum for dialogue on the extent to which the current regulatory paradigm for antidiabetic drug therapies addresses the needs of patients with diabetes and to identify additional outcomes, beyond HbA1c.
 
******************************** 

Resources for Breastfeeding Mothers

FDA has tips to help breastfeeding mothers make informed decisions about FDA regulated products.  Use these tips to educate the women in your community.
******************************** 

Submit Comments on FDA Regulatory Activities

 
This docket is open until August 15, 2016. 
********************************  

OWH Conference Exhibits

 
National Black Nurses Association (NBNA)- August 2-7, Memphis, TN
 
American Association of Diabetes Educators (AADE)- August 12-15, San Diego, CA
 
National Association of Community Health Centers- August 28-30, Chicago, IL

__________________________________________________________________ 

 

 

Contact FDA

301-796-9440
Fax:301-847-8604
Food and Drug Administration Office of Women's Health

10903 New Hampshire Avenue

WO32-2333

Silver Spring, MD 20993

Page Last Updated: 08/11/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.